145 related articles for article (PubMed ID: 22382894)
1. The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia.
Whitman SP; Caligiuri MA; Maharry K; Radmacher MD; Kohlschmidt J; Becker H; Mrózek K; Wu YZ; Schwind S; Metzeler KH; Mendler JH; Wen J; Baer MR; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Larson RA; Marcucci G; Bloomfield CD
Leukemia; 2012 Jul; 26(7):1713-7. PubMed ID: 22382894
[No Abstract] [Full Text] [Related]
2. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
[TBL] [Abstract][Full Text] [Related]
3. The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia.
Kong J; Zhao XS; Qin YZ; Zhu HH; Jia JS; Jiang Q; Wang J; Zhao T; Huang XJ; Jiang H
Leuk Lymphoma; 2018 Apr; 59(4):967-972. PubMed ID: 28745571
[TBL] [Abstract][Full Text] [Related]
4. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F
Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD.
Chien W; Sun QY; Ding LW; Mayakonda A; Takao S; Liu L; Lim SL; Tan KT; Garg M; De Sousa Maria Varela A; Xiao J; Jacob N; Behrens K; Stocking C; Lill M; Madan V; Hattori N; Gery S; Ogawa S; Wakita S; Ikezoe T; Shih LY; Alpermann T; Haferlach T; Yang H; Koeffler HP
Leukemia; 2017 Mar; 31(3):762-766. PubMed ID: 27881871
[No Abstract] [Full Text] [Related]
6. Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.
Whitman SP; Ruppert AS; Marcucci G; Mrózek K; Paschka P; Langer C; Baldus CD; Wen J; Vukosavljevic T; Powell BL; Carroll AJ; Kolitz JE; Larson RA; Caligiuri MA; Bloomfield CD
Blood; 2007 Jun; 109(12):5164-7. PubMed ID: 17341662
[TBL] [Abstract][Full Text] [Related]
7. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
[TBL] [Abstract][Full Text] [Related]
8. Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
Zorko NA; Bernot KM; Whitman SP; Siebenaler RF; Ahmed EH; Marcucci GG; Yanes DA; McConnell KK; Mao C; Kalu C; Zhang X; Jarjoura D; Dorrance AM; Heerema NA; Lee BH; Huang G; Marcucci G; Caligiuri MA
Blood; 2012 Aug; 120(5):1130-6. PubMed ID: 22674806
[TBL] [Abstract][Full Text] [Related]
9. The MLL partial tandem duplication in acute myeloid leukaemia.
Basecke J; Whelan JT; Griesinger F; Bertrand FE
Br J Haematol; 2006 Nov; 135(4):438-49. PubMed ID: 16965385
[TBL] [Abstract][Full Text] [Related]
10. miR-101 suppresses the development of
Gonzales-Aloy E; Connerty P; Salik B; Liu B; Woo AJ; Haber M; Norris MD; Wang J; Wang JY
Haematologica; 2019 Jul; 104(7):e296-e299. PubMed ID: 30792205
[No Abstract] [Full Text] [Related]
11. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
Vetro C; Haferlach T; Meggendorfer M; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2020 Jan; 240():15-22. PubMed ID: 31698332
[TBL] [Abstract][Full Text] [Related]
12. A novel regimen for relapsed/refractory adult acute myeloid leukemia using a
Mims AS; Mishra A; Orwick S; Blachly J; Klisovic RB; Garzon R; Walker AR; Devine SM; Walsh KJ; Vasu S; Whitman S; Marcucci G; Jones D; Heerema NA; Lozanski G; Caligiuri MA; Bloomfield CD; Byrd JC; Piekarz R; Grever MR; Blum W
Haematologica; 2018 Jun; 103(6):982-987. PubMed ID: 29567781
[No Abstract] [Full Text] [Related]
13. Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene.
Ommen HB; Hokland P; Haferlach T; Abildgaard L; Alpermann T; Haferlach C; Kern W; Schnittger S
Br J Haematol; 2014 Jun; 165(5):618-28. PubMed ID: 24611505
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID mice.
Hayashi M; Kondoh K; Nakata Y; Kinoshita A; Mori T; Takahashi T; Sakamoto MI; Yamada T
Br J Haematol; 2007 May; 137(3):221-32. PubMed ID: 17408461
[TBL] [Abstract][Full Text] [Related]
15. Molecular mutations are prognostically relevant in AML with intermediate risk cytogenetics and aberrant karyotype.
Bacher U; Haferlach T; Alpermann T; Kern W; Schnittger S; Haferlach C
Leukemia; 2013 Feb; 27(2):496-500. PubMed ID: 22858909
[No Abstract] [Full Text] [Related]
16. The Application of Targeted RNA Sequencing for KMT2A-Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia.
Dai B; Yu H; Ma T; Lei Y; Wang J; Zhang Y; Lu J; Yan H; Jiang L; Chen B
J Mol Diagn; 2021 Nov; 23(11):1478-1490. PubMed ID: 34384895
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique.
Balgobind BV; Hollink IH; Reinhardt D; van Wering ER; de Graaf SS; Baruchel A; Stary J; Beverloo HB; de Greef GE; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
Eur J Cancer; 2010 Jul; 46(10):1892-9. PubMed ID: 20233657
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432
[TBL] [Abstract][Full Text] [Related]
19. Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD).
Sun QY; Ding LW; Tan KT; Chien W; Mayakonda A; Lin DC; Loh XY; Xiao JF; Meggendorfer M; Alpermann T; Garg M; Lim SL; Madan V; Hattori N; Nagata Y; Miyano S; Yeoh AE; Hou HA; Jiang YY; Takao S; Liu LZ; Tan SZ; Lill M; Hayashi M; Kinoshita A; Kantarjian HM; Kornblau SM; Ogawa S; Haferlach T; Yang H; Koeffler HP
Leukemia; 2017 Jan; 31(1):1-10. PubMed ID: 27389053
[TBL] [Abstract][Full Text] [Related]
20. The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome.
Caligiuri MA; Strout MP; Oberkircher AR; Yu F; de la Chapelle A; Bloomfield CD
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3899-902. PubMed ID: 9108076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
